NCT00792272已完成不适用
Prevalence of Aspirin Resistance in Hemodialysis Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 主要终点
- Aspirin Resistance in Hemodialysis patients
研究概览
简要总结
Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients
详细描述
We will try to describe the profile of aspirin resistant patient in hemodialysis patients
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •all hemodialysis patients on aspirin
排除标准
- •low platelets <100.000
- •coagulopathy, bleeding disorders
- •patient on plavix
结局指标
主要结局
Aspirin Resistance in Hemodialysis patients
时间窗: 2 months
次要结局
未报告次要终点
研究者
Suzanne El-Sayegh
Assoc. Chair of Medicine
Northwell Health
相似试验
已完成
不适用
Prevalence of Aspirin Resistance in Chronic Kidney Disease PatientsChronic Kidney DiseaseNCT01364779Northwell Health15
进行中（未招募）
4 期
ASPIrin in Reducing Events in Dialysis ( ASPIRED )CKD (Chronic Kidney Disease) Stage 5DNCT04381143Guangdong Provincial People's Hospital9,082
已完成
不适用
Laboratory Aspirin Resistance in Diabetics and Non-DiabeticsDrug ResistanceNCT00563875University of Aarhus210
已完成
不适用
Danish Aspirin Resistance Trial - Pilot StudyDrug ResistanceNCT00389129University of Aarhus60
Unknown
4 期
Aspirin Resistance Reversibility in Diabetic PatientsAspirin ResistanceNCT01935193Azienda Ospedaliera San Giovanni Battista160